MLICM
EDIT icon

Metropolitan Life Insurance Company (MetLife)’s Editas Medicine EDIT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,989
Closed -$29.6K – 646
2024
Q1 		$29.6K Sell
3,989
-822
-17% -$6.83K ﹤0.01% 1668
2023
Q4 		$48.7K Hold
4,811
– – ﹤0.01% 1461
2023
Q3 		$37.5K Buy
4,811
+1,008
+27% +$8.64K ﹤0.01% 1567
2023
Q2 		$31.3K Buy
3,803
+680
+22% +$5.92K ﹤0.01% 1695
2023
Q1 		$22.6K Sell
3,123
-1,441
-32% -$12.8K ﹤0.01% 1823
2022
Q4 		$40.5K Hold
4,564
– – ﹤0.01% 1598
2022
Q3 		$55.9K Hold
4,564
– – ﹤0.01% 1391
2022
Q2 		$54K Hold
4,564
– – ﹤0.01% 1456
2022
Q1 		$86.8K Sell
4,564
-13,546
-75% -$252K ﹤0.01% 1284
2021
Q4 		$481K Hold
18,110
– – 0.01% 1461
2021
Q3 		$744K Sell
18,110
-1,147
-6% -$62.8K 0.01% 1173
2021
Q2 		$1.09M Buy
19,257
+1,084
+6% +$40K 0.02% 942
2021
Q1 		$763K Buy
18,173
+810
+5% +$46.1K 0.01% 1140
2020
Q4 		$1.22M Sell
17,363
-946
-5% -$38.9K 0.02% 757
2020
Q3 		$514K Buy
18,309
+1,734
+10% +$56.5K 0.01% 1201
2020
Q2 		$490K Hold
16,575
– – 0.01% 1214
2020
Q1 		$329K Hold
16,575
– – 0.01% 1307
2019
Q4 		$491K Hold
16,575
– – 0.01% 1339
2019
Q3 		$377K Buy
16,575
+1,287
+8% +$31.9K 0.01% 1466
2019
Q2 		$378K Buy
15,288
+342
+2% +$8.16K 0.01% 1483
2019
Q1 		$365K Hold
14,946
– – 0.01% 1496
2018
Q4 		$340K Hold
14,946
– – 0.01% 1475
2018
Q3 		$476K Hold
14,946
– – 0.01% 1400
2018
Q2 		$536K Buy
14,946
+3,192
+27% +$113K 0.01% 1273
2018
Q1 		$390K Hold
11,754
– – 0.01% 1442
2017
Q4 		$361K Sell
11,754
-12,248
-51% -$308K ﹤0.01% 1501
2017
Q3 		$576K Hold
24,002
– – ﹤0.01% 1587
2017
Q2 		$403K Buy
+24,002
New +$433K ﹤0.01% 1863
2016
Q3 		– Sell
-7,426
Closed -$181K – 2640
2016
Q2 		$181K Buy
+7,426
New +$251K ﹤0.01% 2384

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s EDIT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 3,989 shares — an estimated $29.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in EDIT in Q2 2016 and held it in 29 quarters. The position peaked at $1.22M in Q4 2020. 236 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,989 Editas Medicine shares in Q2 2024, an estimated $29.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Editas Medicine in Q2 2016 and held it in 29 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Editas Medicine position peaked at $1.22M in Q4 2020.
  • 236 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.